Multiple Myeloma and Diabetes
ISRN Endocrinology · 2011
DOI: 10.5402/2011/815013 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Endocrinology, 2011. Verfasst von Zeinab A Issa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, American University of Beirut-Medical Center, 3 Dag Hammarskjold Plaza, 8t…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, American University of Beirut-Medical Center, 3 Dag Hammarskjold Plaza, 8th floor, New York, NY 10017, USA.
Zitieren
APA
Issa, Z. A., Zantout, M. S., & Azar, S. T. (2011). Multiple Myeloma and Diabetes. ISRN Endocrinology. https://doi.org/10.5402/2011/815013
Vancouver
Issa ZA, Zantout MS, Azar ST. Multiple Myeloma and Diabetes. ISRN Endocrinology. 2011. doi:10.5402/2011/815013
BibTeX
@article{Issa2011,
author = {Issa, Zeinab A and Zantout, Mira S and Azar, Sami T},
title = {Multiple Myeloma and Diabetes},
journal = {ISRN Endocrinology},
year = {2011},
doi = {10.5402/2011/815013}
}
EUVIMED